Gainers & Losers
Tue Jul 15 2025 10:17:37- Sun Pharmaceutical Industr...
- ₹1,727.702.71%
- Bajaj Finserv share price
- ₹2,037.451.69%
- Indusind Bank share price
- ₹881.101.61%
- Tata Motors share price
- ₹684.951.55%
- Wipro share price
- ₹257.501.32%
Active Stocks
Tue Jul 15 2025 10:16:43- Gail India share price
- ₹184.750.60%
- Hdfc Bank share price
- ₹1,995.300.62%
- Indian Hotels Co share price
- ₹745.502.42%
- Icici Bank share price
- ₹1,430.900.57%
- Zee Entertainment Enterpri...
- ₹143.250.17%
Business News/Market/Market Stats/Glaxosmithkline Pharmaceutical share price/ Glaxosmithkline Pharmaceutical Balance Sheet Annual
Glaxosmithkline Pharmaceutical Balance Sheet Annual
3,193.30 +6.25 (0.20%)Updated : 15 Jul 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 4,108.07 | 3,556.62 | 3,326.58 | 4,633.28 |
| Accumulated Depreciation Total | -295.62 | -283.13 | -255.54 | -222.66 |
| Cash Equivalents | 435.00 | 0.00 | 0.04 | 230.06 |
| Other Liabilities Total | 249.11 | 247.56 | 255.49 | 264.27 |
| Accrued Expenses | 155.98 | 114.21 | 94.71 | 103.08 |
| Common Stock Total | 169.41 | 169.41 | 169.41 | 169.41 |
| Other Current Assets Total | 26.39 | 23.93 | 23.29 | 23.37 |
| Prepaid Expenses | 18.89 | 20.62 | 14.96 | 13.93 |
| Total Assets | 4,108.07 | 3,556.62 | 3,326.58 | 4,633.28 |
| Current Portof LT Debt/ Capital Leases | 7.46 | 12.20 | 12.08 | 12.45 |
| Cash | 103.85 | 64.17 | 34.90 | 56.13 |
| Total Equity | 1,951.31 | 1,777.64 | 1,741.27 | 2,662.96 |
| Long Term Investments | 0.81 | 0.94 | 1.09 | 1.21 |
| Retained Earnings( Accumulated Deficit) | 1,781.90 | 1,608.23 | 1,571.87 | 2,493.55 |
| Total Common Shares Outstanding | 16.94 | 16.94 | 16.94 | 16.94 |
| Property/ Plant/ Equipment Total- Gross | 579.48 | 593.86 | 570.66 | 548.10 |
| Tangible Book Valueper Share Common Eq | 114.40 | 103.54 | 100.77 | 155.16 |
| Total Liabilities | 2,156.75 | 1,778.98 | 1,585.31 | 1,970.32 |
| Total Debt | 9.95 | 18.67 | 15.54 | 20.08 |
| Short Term Investments | 1,959.26 | 1,792.65 | 1,619.18 | 2,544.69 |
| Cashand Short Term Investments | 2,498.10 | 1,856.82 | 1,654.12 | 2,830.88 |
| Total Receivables Net | 384.77 | 371.99 | 341.93 | 305.17 |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Accounts Receivable- Trade Net | 301.50 | 231.07 | 206.45 | 212.88 |
| Property/ Plant/ Equipment Total- Net | 283.86 | 310.73 | 315.12 | 325.45 |
| Total Current Liabilities | 1,905.15 | 1,524.95 | 1,326.37 | 1,698.43 |
| Total Inventory | 481.74 | 525.05 | 459.97 | 534.70 |
| Accounts Payable | 708.25 | 625.41 | 427.79 | 570.55 |
| Other Currentliabilities Total | 1,033.47 | 773.13 | 791.79 | 1,012.35 |
| Total Long Term Debt | 2.49 | 6.47 | 3.46 | 7.62 |
| Intangibles Net | 13.33 | 23.55 | 34.09 | 34.50 |
| Other Long Term Assets Total | 185.68 | 191.70 | 179.84 | 157.02 |
| Note Receivable- Long Term | 214.50 | 231.27 | 302.18 | 407.07 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 3,409.88 | 2,798.42 | 2,494.26 | 3,708.03 |
| Capital Lease Obligations | 2.49 | 6.47 | 3.46 | 7.62 |
*All figures in crores except per share values
Glaxosmithkline Pharmaceutical Quick Links
Glaxosmithkline Pharmaceutical Dividend Glaxosmithkline Pharmaceutical Bonus Glaxosmithkline Pharmaceutical News Glaxosmithkline Pharmaceutical AGM Glaxosmithkline Pharmaceutical Rights Glaxosmithkline Pharmaceutical Splits Glaxosmithkline Pharmaceutical Board Meetings Glaxosmithkline Pharmaceutical Key Metrics Glaxosmithkline Pharmaceutical Shareholdings Glaxosmithkline Pharmaceutical Profit Loss Glaxosmithkline Pharmaceutical Cashflow Glaxosmithkline Pharmaceutical Q1 Results Glaxosmithkline Pharmaceutical Q2 Results Glaxosmithkline Pharmaceutical Q3 Results Glaxosmithkline Pharmaceutical Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,727.70+45.65(2.71%)
2,037.45+33.80(1.69%)
881.10+13.95(1.61%)
1,566.35-53.60 (-3.31%)
159.05-1.30 (-0.81%)